Latest Diabetes management Stories
PARIS, June 14, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that Lyxumia(®) (lixisenatide) met the primary endpoint in an 8-week head-to-head pharmacodynamic study
During the 1-year program, patients showed statistically significant reductions in blood glucose levels, increased belief in their ability to self-manage their diabetes and improved perceptions of
Once-Weekly Dulaglutide 1.5 mg Also Demonstrates Weight Loss, Low Rates of Hypoglycemia in AWARD-6 Trial SAN FRANCISCO, June 14, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today
Companies present comprehensive data for LY2963016, investigational new insulin glargine product SAN FRANCISCO, June 14, 2014 /PRNewswire/ -- For the first time today, Eli Lilly and Company
Announces Simple Savings Program to Make Test Strip Replacement Convenient and Affordable, Essentially Eliminating the Need for Insurance Reimbursement MOUNTAIN VIEW, Calif., June
ROCKVILLE, Md., June 10, 2014 /PRNewswire-USNewswire/ -- Patients with type 2 diabetes who take a combination of metformin plus insulin may be at higher risk for cardiovascular disease and death
Phase 3 Study Results Across Different Patient Populations, Including Comparative Analyses with Sitagliptin and Health Economics Data, are Among 15 Accepted Presentations RARITAN, N.J., June
While diabetes has been a major public health threat in the US for some time, a new report published in the journal BMJ Open has found that rates of pre-diabetes in England have risen sharply.
Company to highlight late-stage pipeline molecules, including once-weekly dulaglutide and basal insulin peglispro INDIANAPOLIS, June 9, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY)
RnRMarketResearch.com adds “Blood Glucose Testing and Diabetes Management” to its store.
Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....
- The act of sweetening by admixture of some saccharine substance.